Related Experiment Video
Updated: Jul 19, 2026
08:59
Utilizing the Precision-Cut Lung Slice to Study the Contractile Regulation of Airway and Intrapulmonary Arterial Smooth Muscle
Published on: May 5, 2022
Airway smooth muscle and asthma
Brian G Oliver1, Judith L Black
1School of Medical Sciences Pharmacology, University of Sydney, NSW, Australia.
Summary
Airway smooth muscle plays a key role in asthma. Research suggests inherent muscle abnormalities, including supercontractility and altered proliferation, contribute to the asthmatic phenotype, necessitating further investigation for targeted therapies.
Area of Science:
- Pulmonary Medicine
- Cell Biology
- Immunology
Background:
- Airway smooth muscle (ASM) is central to airway narrowing in asthma.
- Its function in non-diseased states is poorly understood.
- Emerging evidence suggests intrinsic ASM abnormalities in asthma.
Purpose of the Study:
- To investigate the intrinsic properties of ASM in asthma.
- To explore potential mechanisms underlying ASM dysfunction in asthmatic individuals.
- To identify therapeutic targets for airway remodeling in asthma.
Main Methods:
- In vitro analysis of ASM properties from asthmatic and non-asthmatic individuals.
- Examination of ASM proliferation, contractility, and extracellular matrix interactions.
- Assessment of transcription factor expression (e.g., C/EBP-alpha) and mediator release (e.g., PGE2).
Main Results:
- Asthmatic ASM exhibits potential "supercontractility" and increased proliferation.
- Absence of inhibitory transcription factor C/EBP-alpha may contribute to proliferation.
- Altered extracellular matrix and decreased PGE2 release may influence ASM behavior.
Conclusions:
- Intrinsic ASM abnormalities, including hypercontractility and altered proliferation, are implicated in asthma.
- Current treatments may not fully address structural changes like airway remodeling.
- Further research into ASM mechanisms is crucial for developing novel therapeutic interventions for asthma.
Related Concept Videos
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
01:19Factors Affecting Pulmonary Ventilation
Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...